Fernando Ramos

A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group.

Miguel Á. Sanz, Consuelo Rayón, Jordi Esteve et al. · PubMed · 1999 · 410 citations

Medicine, Oncology, Pharmacology +15

Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification

Jesús F. San Miguel, María‐Belén Vídriales, C López-Berges et al. · Blood · 2001 · 332 citations · Full text

Medicine, Hematology, Oncology +16

Immunophenotyping Investigation of Minimal Residual Disease Is a Useful Approach for Predicting Relapse in Acute Myeloid Leukemia Patients

Jesús F. San Miguel, Antônio Vaz de Macedo, María‐Belén Vídriales et al. · Blood · 1997 · 274 citations · Full text

Medicine, Hematology, Oncology +16

Cytogenetic risk stratification in chronic myelomonocytic leukemia

Esperanza Such, J. Cervera, Dolors Costa et al. · Haematologica · 2010 · 264 citations · Full text

Life Sciences, Hematology, Oncology +15

Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies.

Clara Bueno, Júlia Almeida, Paulo Lúcio et al. · PubMed · 2004 · 123 citations

Medicine, Hematology, Oncology +17